PT2381925T - Utilização de uma composição expansível essencialmente isenta de ingredientes farmaceuticamente ativos para o tratamento da pele humana - Google Patents

Utilização de uma composição expansível essencialmente isenta de ingredientes farmaceuticamente ativos para o tratamento da pele humana

Info

Publication number
PT2381925T
PT2381925T PT97990451T PT09799045T PT2381925T PT 2381925 T PT2381925 T PT 2381925T PT 97990451 T PT97990451 T PT 97990451T PT 09799045 T PT09799045 T PT 09799045T PT 2381925 T PT2381925 T PT 2381925T
Authority
PT
Portugal
Prior art keywords
treatment
active ingredients
pharmaceutically active
human skin
essentially free
Prior art date
Application number
PT97990451T
Other languages
English (en)
Inventor
Graupe Klaus
Städtler Gerald
Original Assignee
Intendis Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40796237&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2381925(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intendis Gmbh filed Critical Intendis Gmbh
Publication of PT2381925T publication Critical patent/PT2381925T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT97990451T 2008-12-23 2009-12-22 Utilização de uma composição expansível essencialmente isenta de ingredientes farmaceuticamente ativos para o tratamento da pele humana PT2381925T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14015208P 2008-12-23 2008-12-23
EP08022333A EP2210588B1 (en) 2008-12-23 2008-12-23 Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin

Publications (1)

Publication Number Publication Date
PT2381925T true PT2381925T (pt) 2017-06-23

Family

ID=40796237

Family Applications (2)

Application Number Title Priority Date Filing Date
PT08022333T PT2210588E (pt) 2008-12-23 2008-12-23 Composição expansível, essencialmente isenta de ingredientes farmaceuticamente activos para o tratamento da pele humana
PT97990451T PT2381925T (pt) 2008-12-23 2009-12-22 Utilização de uma composição expansível essencialmente isenta de ingredientes farmaceuticamente ativos para o tratamento da pele humana

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT08022333T PT2210588E (pt) 2008-12-23 2008-12-23 Composição expansível, essencialmente isenta de ingredientes farmaceuticamente activos para o tratamento da pele humana

Country Status (33)

Country Link
US (2) US8658138B2 (pt)
EP (2) EP2210588B1 (pt)
JP (2) JP5795261B2 (pt)
KR (1) KR20110103972A (pt)
CN (1) CN102325522B (pt)
AR (1) AR074839A1 (pt)
AT (1) ATE500817T1 (pt)
AU (1) AU2009331845B2 (pt)
BR (1) BRPI0923589B1 (pt)
CA (1) CA2748346C (pt)
CL (1) CL2011001468A1 (pt)
CO (1) CO6390034A2 (pt)
CR (1) CR20110337A (pt)
CU (1) CU20110132A7 (pt)
DE (1) DE602008005497D1 (pt)
DK (2) DK2210588T3 (pt)
EA (1) EA021762B1 (pt)
EC (1) ECSP11011137A (pt)
ES (2) ES2364692T3 (pt)
HR (2) HRP20170865T1 (pt)
HU (1) HUE034651T2 (pt)
IL (1) IL213359A (pt)
MX (1) MX2011006381A (pt)
NZ (1) NZ593575A (pt)
PE (1) PE20120109A1 (pt)
PL (2) PL2210588T3 (pt)
PT (2) PT2210588E (pt)
SG (1) SG171948A1 (pt)
SV (1) SV2011003948A (pt)
TW (1) TW201034695A (pt)
UA (1) UA106062C2 (pt)
WO (1) WO2010072422A1 (pt)
ZA (1) ZA201104600B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
DE602008005497D1 (de) * 2008-12-23 2011-04-21 Intendis Gmbh Schäumbare Zusammensetzung, die im Wesentlichen frei von pharmazeutisch aktiven Inhaltsstoffen ist, zur Behandlung der menschlichen Haut
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
RU2505291C2 (ru) * 2009-06-24 2014-01-27 СТРАТЕДЖИК САЙЕНС ЭНД ТЕКНОЛОДЖИЗ, ЭлЭлСи Топическая композиция, содержащая ибупрофен
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
EP2482788B1 (en) 2009-10-02 2022-12-14 Journey Medical Corporation Topical tetracycline compositions
ES2811515T3 (es) 2010-12-29 2021-03-12 Strategic Science & Tech Llc Tratamiento de disfunción eréctil y otras indicaciones
FR2994386B1 (fr) * 2012-08-07 2016-06-24 Thorel Jean-Noel Inhibition de l'adhesion de micro-organismes pathogenes par un ester de saccharose et/ou de sorbitan dans le traitement cosmetique de l'atopie cutanee
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CN108938674A (zh) * 2017-05-27 2018-12-07 福建省山河药业有限公司 红色诺卡氏菌细胞壁骨架在制备治疗皮肤病变药物中的用途
FR3069775B1 (fr) * 2017-08-02 2020-02-14 Roquette Freres 1,4 :3,6 dianhydrohexitols pour hydrater la peau
BR112021016100A2 (pt) 2019-03-06 2021-11-09 Isdin Sa Uso de triglicerídeos caprílicos e cápricos para o tratamento de uma doença ou condição mediada por deficiência de filagrina ou colágeno

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE29825037U1 (de) * 1997-08-18 2004-04-29 Neubourg, Stephanie Schaum-Hautcreme mit Harnstoff
JP4057234B2 (ja) * 1997-08-18 2008-03-05 ノイブルグ スキン ケア ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 泡状スキンクリーム、泡状スキンプロテクションクリームの使用及びその製造方法
GB9903639D0 (en) * 1999-02-17 1999-04-07 Unilever Plc Liquid cleansing composition
JP4190303B2 (ja) * 2002-02-18 2008-12-03 日本精化株式会社 カチオン性共重合体
IL152486A0 (en) * 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20050069566A1 (en) 2003-08-04 2005-03-31 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US9265725B2 (en) * 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
CA2536482C (en) 2003-08-25 2012-07-24 Foamix Ltd. Penetrating pharmaceutical foam
JP4722434B2 (ja) * 2004-08-31 2011-07-13 株式会社ダイゾー 発泡性エアゾール組成物
AU2006298442A1 (en) * 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
WO2008038140A2 (en) * 2006-06-07 2008-04-03 Foamix Ltd. Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof
CN101563058A (zh) * 2006-09-08 2009-10-21 弗米克斯有限公司 有色的或可着色的能起泡的组合物和泡沫
JP4851907B2 (ja) * 2006-10-05 2012-01-11 Ｎｅｃディスプレイソリューションズ株式会社 ポンプユニットおよびそれを用いたプロジェクタ
DE602008005497D1 (de) * 2008-12-23 2011-04-21 Intendis Gmbh Schäumbare Zusammensetzung, die im Wesentlichen frei von pharmazeutisch aktiven Inhaltsstoffen ist, zur Behandlung der menschlichen Haut

Also Published As

Publication number Publication date
PL2210588T3 (pl) 2011-09-30
CO6390034A2 (es) 2012-02-29
ECSP11011137A (es) 2011-08-31
IL213359A0 (en) 2011-07-31
DK2210588T3 (da) 2011-06-27
TW201034695A (en) 2010-10-01
EP2210588B1 (en) 2011-03-09
MX2011006381A (es) 2011-09-27
BRPI0923589A2 (pt) 2016-07-26
ES2628218T3 (es) 2017-08-02
CU20110132A7 (es) 2012-01-31
SG171948A1 (en) 2011-07-28
CA2748346C (en) 2017-08-22
PE20120109A1 (es) 2012-02-08
AR074839A1 (es) 2011-02-16
EA021762B1 (ru) 2015-08-31
NZ593575A (en) 2013-08-30
WO2010072422A1 (en) 2010-07-01
BRPI0923589B1 (pt) 2019-04-24
US8986658B2 (en) 2015-03-24
US20100247449A1 (en) 2010-09-30
PL2381925T3 (pl) 2017-09-29
PT2210588E (pt) 2011-06-07
HRP20170865T1 (hr) 2017-09-08
CN102325522B (zh) 2013-12-25
HRP20110429T1 (hr) 2011-08-31
CL2011001468A1 (es) 2012-02-17
ZA201104600B (en) 2022-03-30
JP2015157860A (ja) 2015-09-03
JP5795261B2 (ja) 2015-10-14
CN102325522A (zh) 2012-01-18
CR20110337A (es) 2011-12-28
ES2364692T3 (es) 2011-09-12
ATE500817T1 (de) 2011-03-15
EP2381925A1 (en) 2011-11-02
HK1166263A1 (en) 2012-10-26
DE602008005497D1 (de) 2011-04-21
EA201170876A1 (ru) 2012-02-28
US20140190854A1 (en) 2014-07-10
IL213359A (en) 2014-09-30
DK2381925T3 (da) 2017-06-26
SV2011003948A (es) 2011-12-06
AU2009331845A1 (en) 2011-06-30
UA106062C2 (uk) 2014-07-25
US8658138B2 (en) 2014-02-25
AU2009331845B2 (en) 2015-11-12
EP2381925B1 (en) 2017-03-15
KR20110103972A (ko) 2011-09-21
JP2012513430A (ja) 2012-06-14
CA2748346A1 (en) 2010-07-01
HUE034651T2 (en) 2018-02-28
EP2210588A1 (en) 2010-07-28

Similar Documents

Publication Publication Date Title
IL213359A0 (en) Use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
IL217901B (en) Use of laquinimod or a laquinimod salt in the manufacture of a drug for the treatment of bdnf-related diseases
IL207546A0 (en) Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
IL206080A0 (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
ZA201200017B (en) Formulations for the treatment of deeep tissue pain
IL216967B (en) The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases
ZA201104079B (en) Therapeutic,dietary,or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3,and compositions containing these compounds
IL215840A (en) Arylsulfonamide compounds are converted into two positions 2 and 5, their pharmaceutical composition containing them and their use in the treatment of ccr3-related diseases
EP2063902A4 (en) THERAPEUTIC CELL MEDICAMENT WITH STEM CELLS OF SKIN
IL215831A (en) A drug containing allopurinol for use in the treatment of hand-foot skin reaction
IL213703A (en) Compounds for the treatment of pain and other diseases
PL2640364T3 (pl) Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych
IL215460A (en) Use of vip-containing compositions for the manufacture of medications for the prevention or treatment of osteoporosis and diarrhea
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders
PL2424602T3 (pl) System do dostarczania środka leczniczego do skóry pacjenta
GB2411834B (en) Composition for use in the treatment of dry skin conditions
GB0813004D0 (en) Stable therapeutic formulation of human growth hormone
GB0616122D0 (en) Formulation for treatment of skin disorders
GB0503214D0 (en) Compositions for therapeutic treatment of skin and other conditions
GB0819037D0 (en) Skin treatment formulation
GB0716834D0 (en) New formulation for treatment of skin disorders
AU2006900256A0 (en) Skin formulation usable as a therapeutic application for the treatment of general skin disorders and a method of preparation thereof
IL189569A0 (en) Cosmetic and dermatological composition for psoriatic skin treatment
AU2007905499A0 (en) Skin Treatment Formulation